These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1149649)

  • 1. Miconazole: a review of its antifungal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1975; 9(6):406-23. PubMed ID: 1149649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery
    Drugs; 1975; 9(6):424-47. PubMed ID: 1097234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Econazole: a review of its antifungal activity and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Sep; 16(3):177-201. PubMed ID: 98315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.
    Jevons S; Gymer GE; Brammer KW; Cox DA; Leeming MR
    Antimicrob Agents Chemother; 1979 Apr; 15(4):597-602. PubMed ID: 464592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tioconazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.
    Clissold SP; Heel RC
    Drugs; 1986 Jan; 31(1):29-51. PubMed ID: 3510114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.
    Van Cutsem JM; Thienpont D
    Chemotherapy; 1972; 17(6):392-404. PubMed ID: 4563141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of an orally and a locally administered antifungal agent in vaginal mycoses].
    Farkas B; Simon N
    Mykosen; 1984 Nov; 27(11):554-61. PubMed ID: 6097818
    [No Abstract]   [Full Text] [Related]  

  • 9. Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jan; 19(1):7-30. PubMed ID: 6988200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical fenticonazole in dermatology and gynaecology: current role in therapy.
    Veraldi S; Milani R
    Drugs; 2008; 68(15):2183-94. PubMed ID: 18840006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimycotic activity of alpha-aryl-beta,N-imidazolylalkyl benzyl ethers.
    Tajana A; Cappelletti R; Leonardi A; Nardi D; Veronese M
    Arzneimittelforschung; 1981; 31(12):2121-3. PubMed ID: 6800383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
    Choukri F; Benderdouche M; Sednaoui P
    J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of vulvovaginal candidosis during pregnancy. Comparison of miconazole vs nystatin treatment.
    Wallenburg HC; Wladimiroff JW
    Obstet Gynecol; 1976 Oct; 48(4):491-4. PubMed ID: 787858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.
    Dixon D; Shadomy S; Shadomy HJ; Espinel-Ingroff A; Kerkering TM
    J Infect Dis; 1978 Aug; 138(2):245-8. PubMed ID: 681800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent.
    Dyer RL; Ellames GJ; Hamill BJ; Manley PW; Pope AM
    J Med Chem; 1983 Mar; 26(3):442-5. PubMed ID: 6298430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.
    Lackner TE; Clissold SP
    Drugs; 1989 Aug; 38(2):204-25. PubMed ID: 2670516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The reaction of the physiological vaginal flora to topical antimycotics (author's transl)].
    Hantschke D; Zabel M
    Mykosen; 1979 Aug; 22(8):267-73. PubMed ID: 398447
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of chronic oropharyngo-esophageal candidiasis with immunological deficiency: successful treatment with miconazole.
    Tytgat GN; Surachno S; de Groot WP; Schellekens PT
    Gastroenterology; 1977 Mar; 72(3):536-40. PubMed ID: 832803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.